Related by context. All words. (Click for frequent words.) 63 ASA# 63 Canvaxin 63 figitumumab 62 Recentin 62 abiraterone 62 Zactima 62 clazosentan 61 motesanib 60 aleglitazar 60 TroVax 60 Nexavar sorafenib 60 Vitaxin 60 axitinib 60 iniparib 60 Targretin 60 ocrelizumab 60 taranabant 59 tremelimumab 59 Ceflatonin 59 PTK ZK 59 vandetanib 59 Xinlay 59 Xyotax 59 gepirone ER 59 rEV# 59 baminercept 59 Aplidin 59 Rezular 59 drug figitumumab 58 Fablyn 58 tesmilifene 58 riociguat 58 cediranib 58 TBC# 58 Relovair 58 otelixizumab 58 Sanofi Aventis Taxotere 58 Insegia 58 elotuzumab 58 erlotinib Tarceva 58 ambrisentan 58 regorafenib 58 phase IIb trial 57 ProSavin 57 enoximone 57 daclizumab 57 Tocosol Paclitaxel 57 apremilast 57 Itopride 57 pertuzumab 57 almorexant 57 HuMax CD4 57 Lu AA# 57 CDP# 57 dirucotide 57 lumiliximab 57 Cinquil 57 Asentar 57 rolofylline 57 Desmoteplase 57 Zybrestat 56 XmAb# 56 motavizumab 56 Preos 56 midstage studies 56 Merck KGaA Erbitux 56 phase IIb clinical 56 sunitinib 56 Cerovive 56 BRAF inhibitor 56 Telcyta 56 metastatic renal cell carcinoma 56 ximelagatran 56 temsirolimus 56 HuMax CD# 56 RoActemra 56 QVA# 56 Galida 56 Mylotarg 56 phase IIb 56 Pirfenidone 56 atrasentan 56 glufosfamide 56 GSK# [001] 56 cabazitaxel 56 HuMax EGFr 56 Amrubicin 56 Torisel 55 ixabepilone 55 phase IIa 55 Vertex telaprevir 55 metastatic castration resistant 55 Avastin bevacizumab 55 Certriad 55 Bicifadine 55 Celgene Revlimid 55 LAF# 55 midstage clinical trial 55 Folotyn 55 Sutent sunitinib 55 Tarceva erlotinib 55 Theratope 55 blinatumomab 55 Ambrisentan 55 HuLuc# 55 abiraterone acetate 55 BAY #-# 55 Velcade bortezomib 55 mRCC 55 bifeprunox 55 muraglitazar 55 zalutumumab 55 alvespimycin 55 Erbitux cetuximab 55 NVA# 55 antiangiogenic agents 55 Lupuzor 55 Juvista 55 GVAX 55 ATL# [001] 55 T DM1 55 sorafenib Nexavar 55 Atrasentan 55 Pimavanserin 55 enzastaurin 55 canakinumab 55 methylnaltrexone 55 ZOLINZA 55 Cogane 55 EGFR TKI 55 phase Ib 55 Vivus Qnexa 54 Prestara 54 arzoxifene 54 PF # [002] 54 Gattex 54 efficacy endpoint 54 Arranon 54 MyVax 54 tocilizumab 54 Balaglitazone 54 trastuzumab DM1 54 mapatumumab 54 sitaxsentan 54 tafamidis 54 NV1FGF 54 Tavocept 54 midstage clinical 54 RSR# 54 bapineuzumab 54 pulmonary arterial hypertension PAH 54 Simdax 54 Bifeprunox 54 Mycograb 54 terlipressin 54 CIMZIA ™ 54 registrational 54 mTOR inhibitor 54 prostate cancer CRPC 54 Pfizer Sutent 54 Nuvion 54 dexanabinol 54 Dacogen injection 54 vismodegib 54 YONDELIS 54 Vernakalant 54 relapsed GBM 54 asenapine 54 Viramidine 54 Orathecin 54 Exanta 54 ruxolitinib 54 PSN# [002] 54 elacytarabine 54 cetuximab Erbitux 54 Oglemilast 54 eprotirome 54 Vidaza azacitidine 54 TroVax ® 54 Zolinza 54 Mipomersen 54 Sulonex 54 Adentri 54 IV NSCLC 54 pradefovir 54 canagliflozin 54 Ixempra 54 Genentech Rituxan 54 ruboxistaurin 54 alvimopan 54 safinamide 54 teplizumab 54 telcagepant 54 experimental hepatitis C 54 pomalidomide 54 cannabinor 54 elesclomol 54 MabThera rituximab 54 tanespimycin 53 epratuzumab 53 fingolimod 53 VEGF Trap 53 custirsen 53 Benlysta belimumab 53 vemurafenib 53 Herceptin trastuzumab 53 bosutinib 53 Telintra 53 bardoxolone 53 BRIM2 53 torcetrapib atorvastatin 53 CytoFabTM 53 Dasatinib 53 Vectibix panitumumab 53 valopicitabine 53 Corlux 53 lintuzumab 53 Pixuvri 53 Rituxan rituximab 53 Xelox 53 Orexigen Contrave 53 KNS # 53 macitentan 53 lomitapide 53 brivaracetam 53 Archexin 53 midstage trials 53 QNEXA 53 alogliptin 53 OvaRex ® MAb 53 adjuvant colon cancer 53 dexpramipexole 53 EVIZON 53 bicifadine 53 JAK inhibitor 53 PSMA ADC 53 Dendreon Provenge 53 Gleevec imatinib 53 EndoTAG TM -1 53 aflibercept 53 PRT# 53 Zometa zoledronic acid 53 Votrient 53 corticosteroid dexamethasone 53 DU #b 53 levosimendan 53 standard chemotherapy regimens 53 mTOR inhibition 53 Fibrillex 53 Liraglutide 53 anidulafungin 53 postoperative chemotherapy 53 incyclinide 53 Certolizumab pegol 53 Alzhemed 53 BRIM3 53 taspoglutide 53 Orazol 53 Fibrillex TM 53 lapatinib Tykerb 53 colorectal cancer liver metastases 53 Treanda 53 solanezumab 53 ELND# 53 alfimeprase 53 ONCONASE R 53 recurrent GBM patients 53 standard chemotherapy regimen 52 Kynapid 52 relapsed ovarian cancer 52 Proxinium TM 52 Plicera 52 metaglidasen 52 velafermin 52 stage IIIB IV 52 Valdoxan 52 teriflunomide 52 chemoradiotherapy 52 Genentech Roche 52 tasocitinib 52 cladribine 52 LymphoStat B 52 PREOS 52 vernakalant 52 ularitide 52 randomized Phase 2b 52 SNT MC# 52 Degludec 52 picoplatin 52 phase IIa clinical 52 indacaterol 52 AZILECT ® 52 sunitinib malate 52 Bydureon 52 virus HCV protease inhibitor 52 Vectibix 52 semagacestat 52 refractory acute myeloid 52 Aflibercept 52 TACI Ig 52 monotherapy 52 Dacogen 52 calcineurin inhibitor 52 Acapodene 52 Promacta 52 idraparinux 52 ataluren 52 volociximab 52 stage IIIb IV 52 rituximab Rituxan 52 pirfenidone 52 PROSTVAC TM 52 Trovax 52 bendamustine 52 zanolimumab 52 anti angiogenic agents 52 Atacand 52 AEGR 52 Xanafide 52 Stage IIIb 52 vidofludimus 52 Tolamba 52 Betaferon ® 52 panitumumab Vectibix 52 paclitaxel poliglumex 52 Doxil 52 Cladribine 52 talactoferrin 52 Indiplon 52 Diamyd ® 52 ABX EGF 52 faropenem 52 gaboxadol 52 SAR# [004] 52 Gaboxadol 52 GALNS 52 ImClone Erbitux 52 forodesine 52 Ocrelizumab 52 desvenlafaxine 52 Taxotere docetaxel 52 TNF inhibitor 52 Ereska 52 drug Pargluva 52 darusentan 52 ACTEMRA TM 52 generation purine nucleoside 52 romidepsin 52 mipomersen 52 Tarceva TM 52 Rezonic 52 Nicox 51 CR# vcMMAE 51 dalbavancin 51 preoperative chemotherapy 51 Synavive 51 Halaven 51 sipuleucel T 51 Tesofensine 51 perampanel 51 Phase Ib II 51 Darusentan 51 Vandetanib 51 pegylated liposomal doxorubicin 51 unresectable stage 51 CytoFab 51 decitabine 51 LymphoStat B belimumab 51 angiogenesis inhibitor 51 Mepact 51 FOLFIRINOX 51 davalintide 51 AGILECT R 51 Syncria 51 midstage clinical trials 51 obatoclax 51 Rasagiline 51 interferon beta 1b 51 Catena ® 51 PegIntron 51 efalizumab 51 denufosol 51 RG# [001] 51 Zytiga 51 Gleevac 51 Afrezza 51 AEG# 51 amrubicin 51 AVE# 51 Tasimelteon 51 UCB Cimzia 51 panitumumab 51 Roche Avastin 51 iniparib BSI 51 Phase Ib study 51 Roche Xeloda 51 CETP inhibitor 51 SILENOR 51 PREOS R 51 FTY# 51 Fosrenol 51 ospemifene 51 TNF alpha inhibitor 51 Antegren 51 Neuvenge 51 Arixtra 51 Amgen Vectibix 51 gefitinib 51 posaconazole 51 Trexima 51 GSK# [002] 51 Gleevec Glivec 51 blood thinner prasugrel 51 Roche Holding AG ROG.VX 51 Avastin 51 multiple myeloma MM 51 Nasulin 51 Yervoy 51 oral Hycamtin 51 exenatide LAR 51 Avastin Tarceva 51 squamous histology 51 ozarelix 51 OMAPRO 51 Safinamide 51 mycophenolate mofetil 51 reslizumab 51 BrachySil 51 edifoligide 51 irbesartan 51 Evoltra 51 Nebido 51 cathepsin K inhibitor 51 placebo controlled clinical 51 Tykerb lapatinib 51 neurologic progression 51 androgen deprivation 51 Novo Nordisk Victoza 51 lixisenatide 50 EOquin 50 rufinamide 50 durable remissions 50 Phase #b/#a 50 tolevamer 50 Phase 2b study 50 sapacitabine 50 OHR/AVR# 50 Phase IIb trials 50 blood clot preventer 50 inhalable insulin product 50 oral Xeloda 50 Oral lyn 50 visilizumab 50 relapsing MS 50 Trastuzumab DM1 50 Asenapine 50 Fodosine 50 YONDELIS R 50 RoACTEMRA 50 HGS# 50 insulin analogs 50 eltrombopag 50 curative resection 50 Abiraterone acetate 50 surrogate endpoint 50 Gleevec imatinib mesylate 50 taxotere 50 Stimuvax R 50 anakinra 50 gemcitabine carboplatin 50 teduglutide 50 IV malignant melanoma 50 imatinib therapy 50 Panitumumab 50 pramlintide 50 liver metastases 50 VIDAZA 50 estramustine 50 MIRCERA 50 concurrent chemoradiation 50 Phenoptin 50 Revlimid lenalidomide 50 vosaroxin 50 locoregional 50 Genentech Herceptin 50 PROSTVAC VF 50 pimavanserin 50 SinuNase 50 investigational hepatitis C 50 thalidomide Thalomid 50 bioabsorbable stent 50 nab paclitaxel 50 TNFerade 50 atacicept 50 refractory metastatic 50 aclidinium bromide 50 Flutiform 50 iclaprim 50 Erbitux 50 Yondelis 50 Galvus 50 inhaled iloprost 50 TELINTRA 50 ThGRF 50 Cetrorelix 50 CIMZIA TM 50 PF # [001] 50 frovatriptan 50 SRT# [003] 50 ridaforolimus 50 ulimorelin 50 Cancidas 50 oral antidiabetic agents 50 Lantus insulin 50 NSABP C 50 INCB# [001] 50 Millennium Velcade 50 nilotinib 50 Panzem 50 adipiplon 50 follicular Non Hodgkin 50 Estorra 50 Torcetrapib 50 Laquinimod 50 FTY# fingolimod 50 Horizant 50 Jevtana 50 Fusilev 50 ponatinib 50 low dose cytarabine 50 aclidinium 50 tenecteplase 50 Vimpat ® lacosamide 50 Tykerb 50 oral ridaforolimus 50 refractory CLL 50 Roche RHHBY 50 Zenapax 50 Allovectin 7 50 omacetaxine 50 Zalbin 50 Leukine 50 complete cytogenetic response 50 albiglutide 50 Phase IIB 50 odanacatib 50 mitoxantrone 50 KIACTA ™ 49 Dapagliflozin 49 S/GSK# 49 erlotinib 49 aplindore 49 gemcitabine chemotherapy 49 Paraplatin 49 Genz # 49 HRPC 49 ADVEXIN therapy 49 anti EGFR antibody 49 Junovan 49 subcutaneous formulation 49 liver metastasis 49 locoregional recurrence 49 AERx iDMS 49 Tracleer 49 Symadex 49 vicriviroc 49 recurrent glioblastoma 49 eniluracil 49 interferon ribavirin 49 rasagiline 49 Cimzia 49 RPL# 49 Actemra tocilizumab 49 tezampanel 49 Pfizer inhaled insulin 49 RANK Ligand inhibitor 49 bortezomib 49 KRAS mutation 49 Orencia abatacept 49 Bapineuzumab 49 MNTX 49 etanercept Enbrel 49 oral cladribine 49 E2F Decoy 49 metastatic gastric 49 Panzem R NCD 49 Telaprevir 49 cancer mCRC 49 diabetic neuropathic pain 49 danoprevir 49 telaprevir 49 coxib 49 ARIKACE ™ 49 rhThrombin 49 Gilenia 49 dacetuzumab 49 Urocidin 49 Contrave# 49 neoadjuvant chemotherapy 49 ispinesib administered 49 Rhucin 49 Doxil ® 49 IRX 2 49 DCCR 49 pemetrexed 49 phase 2a 49 Luveris 49 Elan Tysabri 49 Egrifta 49 ralfinamide 49 Vectibix monotherapy 49 PROCHYMAL 49 Phase IIa trial 49 severe hypercholesterolemia 49 Alfimeprase 49 Phase IIb clinical trials 49 Raptiva R 49 ACZ# 49 dasatinib 49 Golimumab 49 regadenoson 49 Serdaxin 49 Arikace 49 QAB# 49 oxymorphone ER 49 dose escalation Phase 49 compound INCB# 49 Phase 2a trial 49 linaclotide 49 RLY# 49 RhuDex ® 49 AZILECT R 49 Arcalyst 49 Allovectin 7 ® 49 Ceflatonin R 49 YERVOY 49 relapsed AML 49 tumor histology 49 Actemra 49 EGFR inhibitors 49 liposomal formulation 49 APOPTONE 49 Phase III trials 49 sargramostim 49 ganetespib 49 Platinol ® cisplatin 49 TEMODAL 49 Firazyr 49 zileuton 49 Byetta LAR 49 Prosaptide 49 Advexin 49 bardoxolone methyl 49 Starlix 49 Adventrx 49 plus prednisone 49 alemtuzumab Campath 49 PD LID 49 radiographic progression 49 peg interferon 49 Lorqess 49 OncoVEX GM CSF 49 Zavesca 49 Serono SRA 49 denosumab 49 antithrombotic therapy 49 MBP# [001] 49 hematological malignancy 49 doxorubicin docetaxel 49 treprostinil 49 zafirlukast 49 tipranavir 49 endothelin antagonist 48 MK #B 48 prognostic variables 48 cervical cancer vaccine Cervarix 48 metastatic kidney 48 Behcet uveitis 48 AP# [003] 48 hour bronchodilation 48 placebo controlled clinical trials 48 registrational trial 48 KRAS status 48 BCX# 48 antibiotic telavancin 48 stage IIIA 48 Aclidinium 48 Neurodex 48 ONGLYZA ™ 48 Campath alemtuzumab 48 lenalidomide dexamethasone 48 Onbrez Breezhaler 48 Krystexxa 48 PEG SN# 48 deforolimus 48 nonsquamous 48 dose cohort 48 Folfox 48 Rebetol 48 Amigal 48 KRAS mutant tumors 48 Zavesca r 48 cetrorelix 48 Zensana 48 STELARA 48 recurrent metastatic 48 Huntexil 48 velaglucerase alfa 48 ATL/TV# 48 milatuzumab 48 Satraplatin 48 allogeneic HSCT 48 #D#C# 48 gabapentin enacarbil 48 minimally symptomatic 48 albinterferon alfa 2b 48 lung metastasis 48 sustained virologic response 48 oral rivaroxaban 48 relapsed SCLC 48 angiogenesis inhibition 48 IGIV 48 Humira adalimumab 48 Lorianne Masuoka MD 48 Sebivo 48 IGF 1R inhibitor 48 unoprostone isopropyl 48 Tocosol 48 DPP4 48 adjuvant radiation 48 Pfizer Exubera 48 SUTENT ® 48 lurasidone 48 tesofensine 48 irinotecan chemotherapy 48 Byetta exenatide 48 adenoma recurrence 48 Pegintron 48 Xarelto rivaroxaban 48 Serdolect 48 FOLFOX4 48 T Pred 48 Reverset 48 Randomized clinical trials 48 PSA nadir 48 RRMS patients 48 TOCOSOL Paclitaxel 48 antitumor effect 48 Tasigna nilotinib 48 Lodotra TM 48 Arxxant 48 bone metastasis 48 Advagraf 48 Nexavar ® 48 Ilaris 48 indiplon 48 anthracycline containing 48 anti leukemic 48 oral salmon calcitonin 48 palonosetron 48 ITAX 48 intravenous dosing 48 Zomig 48 Novantrone 48 Heplisav 48 oral clodronate 48 oral FTY# 48 CUSTOM III 48 neoadjuvant treatment 48 tramiprosate Alzhemed TM 48 virologic response 48 Numax 48 FOLFIRI 48 Phase IIb clinical 48 Phase #/#a 48 DPP4 inhibitor 48 neoadjuvant therapy 48 paclitaxel carboplatin 48 metastatic lung cancer 48 refractory colorectal cancer 48 carfilzomib 48 apricitabine 48 Octreolin 48 rindopepimut 48 Gralise 48 adjuvant therapy 48 VIAject 48 HAART regimens 47 Santhera 47 Factor Xa inhibitor 47 resected pancreatic cancer 47 post menopausal osteoporosis 47 EGFR expressing mCRC 47 biochemical recurrence 47 ER CHOP 47 Uplyso 47 gp# vaccine 47 everolimus Afinitor 47 Rebif ® 47 methotrexate monotherapy 47 plus dexamethasone 47 glargine 47 Raptiva ® 47 previously untreated follicular 47 liraglutide 47 Rivaroxaban 47 Saphris 47 satraplatin 47 Neurosearch 47 Joulferon 47 orBec 47 immunosuppressive medication 47 nebivolol 47 6R BH4 47 eribulin 47 tumor recurrence 47 heavily pretreated patients 47 roflumilast 47 heavily pretreated 47 sorafenib tablets 47 golimumab 47 vinflunine 47 Certican 47 OncoVEX 47 Hormone Refractory Prostate Cancer 47 Afresa 47 cladribine tablets 47 DPX Survivac 47 Rilutek 47 L BLP# 47 preterm newborns 47 bazedoxifene 47 AML acute myeloid 47 Roche Holding AG RHHBY 47 Shark cartilage 47 relapsed ALL 47 Aryplase 47 Rituxan MabThera 47 Pazopanib 47 efficacy tolerability 47 Provenge prostate cancer 47 Betaferon 47 Neupro 47 blood thinner Xarelto 47 vaccine Oncophage 47 pegylated 47 mCRC patients 47 Study GL# 47 integrase inhibitor 47 prognostic indicators 47 Neovastat 47 mg kg dose 47 DR Cysteamine 47 darunavir 47 attain statistical significance 47 RezularTM 47 KRAS wild 47 Qnexa 47 UPLYSO 47 Naproxcinod 47 Fampridine 47 PEG INTRON 47 Stelara 47 pCR 47 pitavastatin 47 MAXY alpha 47 Xgeva 47 Emselex 47 Noxafil 47 Onglyza saxagliptin 47 Tekamlo 47 immunomodulatory therapy 47 tanezumab 47 chemotherapy docetaxel 47 CTAP# Capsules 47 gemcitabine 47 Keppra XR 47 PhosLo 47 bevacizumab Avastin Genentech 47 celgosivir 47 clinically localized prostate 47 BR.# study 47 glatiramer acetate 47 chemoresistant 47 coronary revascularization 47 Pruvel 47 dacarbazine chemotherapy 47 painkiller Prexige 47 Zerenex 47 amphotericin B 47 Garcia Manero 47 disease progression 47 tumor shrinkage 47 ibandronate 47 antioxidant supplementation 47 Victoza liraglutide 47 INCB# [002] 47 acyclovir Lauriad R 47 ELIQUIS 47 mutated KRAS 47 EGS# 47 Frova 47 Campath 47 biosimilar versions 47 elinogrel 47 paclitaxel cisplatin 47 Icatibant 47 Immunogen 47 generic Lovenox 47 chemoradiation 46 rilpivirine 46 distant metastases 46 localized renal 46 Coreg CR 46 Ketotransdel 46 adjuvant therapies 46 Galvus vildagliptin 46 ceftaroline 46 azilsartan medoxomil 46 BEXXAR Therapeutic Regimen 46 HNSCC 46 randomized multicenter Phase III 46 oblimersen 46 Cimzia TM 46 clobazam 46 tenofovir emtricitabine 46 Xarelto 46 Amevive 46 Lurasidone 46 deferiprone 46 immune reconstitution 46 pamidronate 46 oral anticoagulant 46 TMC# [002] 46 adjuvant cisplatin 46 Vertex hepatitis C 46 Maraviroc 46 small lymphocytic lymphoma 46 Proleukin 46 Saxagliptin 46 ipilimumab 46 sitagliptin 46 Remicade infliximab 46 Enbrel etanercept 46 DEB# 46 natalizumab 46 VEGF inhibition 46 free survival PFS 46 completely resected 46 EGFR mutation positive 46 HCV protease inhibitors 46 prostate cancer CaP 46 Free Survival PFS 46 chronic myeloid 46 Muraglitazar 46 generic Allegra 46 pharmacokinetic PK study 46 peginesatide 46 Fx #A 46 Pegasys plus Copegus 46 intra arterial chemotherapy 46 NEVO ™ 46 #mg BID [001] 46 rivaroxaban 46 Azilect ® 46 NLX P# 46 Albuferon 46 sustained virological response 46 Onyx Pharma 46 underwent resection 46 pancreatic adenocarcinoma 46 Phase IIIb clinical 46 Adjuvant chemotherapy 46 indolent lymphomas 46 demonstrated antitumor activity 46 voclosporin 46 Daxas 46 XGEVA 46 Somatuline Depot 46 chemo radiotherapy 46 PHX# 46 Gabapentin GR 46 inhalable insulin 46 VIDAZA ® 46 Onglyza 46 adjuvant chemotherapy 46 polyp recurrence 46 Acetavance 46 Romiplostim 46 betrixaban 46 topotecan 46 Davanat 46 Kaplan Meier curve 46 postoperative radiotherapy 46 cyclophosphamide chemotherapy 46 pioglitazone Actos 46 Taxus Liberte 46 ACV1 46 hematopoietic cell